Medicare Expands Coverage of Prolaris, Genetic Test for Prostate Cancer Aggressiveness
Medicare coverage for Prolaris genetic test, a tool developed by Myriad Genetics to help predict the aggressiveness of prostate, cancer has been expanded to include patients with favorable intermediate-risk cancer.
Source: Prostate Cancer News Today